代谢综合征及其组分对肾结石形成的影响。
The influence of metabolic syndrome and its components on the development of nephrolithiasis.
作者信息
Boyd Carter, Wood Kyle, Whitaker Dustin, Assimos Dean G
机构信息
University of Alabama-Birmingham School of Medicine, Birmingham, AL, USA.
Department of Urology, University of Alabama-Birmingham, Birmingham, AL, USA.
出版信息
Asian J Urol. 2018 Oct;5(4):215-222. doi: 10.1016/j.ajur.2018.06.002. Epub 2018 Jun 8.
Abstract
The prevalence of kidney stone disease is increasing, afflicting 7%-11% of the United States population. Multiple systemic conditions, including obesity and diabetes, are also on the rise. Further, the literature has demonstrated a strong association between metabolic syndrome, its components, and kidney stone disease. In this article, we aim to review the associations of metabolic syndrome and nephrolithiasis, discussing the pathophysiology, urinary parameters, and clinical presentations. With this knowledge, urologists will have a more comprehensive understanding of this complex population of metabolic stone formers enabling improved patient management and treatment of stone disease.
摘要
肾结石疾病的患病率正在上升，困扰着7%至11%的美国人口。包括肥胖和糖尿病在内的多种全身性疾病也在增加。此外，文献表明代谢综合征及其组成成分与肾结石疾病之间存在密切关联。在本文中，我们旨在综述代谢综合征与肾结石的关联，讨论其病理生理学、尿液参数和临床表现。有了这些知识，泌尿外科医生将对这一复杂的代谢性结石形成人群有更全面的了解，从而能够改善患者管理和结石疾病的治疗。
相似文献
1
The influence of metabolic syndrome and its components on the development of nephrolithiasis.
Asian J Urol. 2018 Oct;5(4):215-222. doi: 10.1016/j.ajur.2018.06.002. Epub 2018 Jun 8.
2
Obesity and kidney stone disease: a systematic review.
Minerva Urol Nefrol. 2018 Aug;70(4):393-400. doi: 10.23736/S0393-2249.18.03113-2. Epub 2018 May 31.
3
Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
Nephrol Dial Transplant. 2011 Jul;26(7):2256-63. doi: 10.1093/ndt/gfq664. Epub 2010 Nov 4.
4
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
5
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
J Endourol. 2017 Dec;31(12):1335-1341. doi: 10.1089/end.2017.0352.
6
Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Urol Res. 2007 Oct;35(5):247-51. doi: 10.1007/s00240-007-0109-1. Epub 2007 Sep 6.
7
Kidney Stone Pathophysiology, Evaluation and Management: Core Curriculum 2023.
Am J Kidney Dis. 2023 Nov;82(5):617-634. doi: 10.1053/j.ajkd.2023.03.017. Epub 2023 Aug 9.
8
Metabolic syndrome and uric acid nephrolithiasis.
Semin Nephrol. 2008 Mar;28(2):174-80. doi: 10.1016/j.semnephrol.2008.01.010.
9
24-h urine metabolic profile: is it necessary in all kidney stone formers?
Int Urol Nephrol. 2018 Jul;50(7):1243-1247. doi: 10.1007/s11255-018-1902-1. Epub 2018 Jun 6.
10
Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
Nephrol Dial Transplant. 2015 Apr;30(4):607-13. doi: 10.1093/ndt/gfu350. Epub 2014 Oct 31.
引用本文的文献
1
Balancing Stone Prevention and Kidney Function: A Therapeutic Dilemma.
J Clin Med. 2025 May 23;14(11):3678. doi: 10.3390/jcm14113678.
2
Association Between Dietary Selenium Intake and Kidney Stones Disease Among Patients with Metabolic Syndrome: A Cross-Sectional Study from the NHANES Database.
J Multidiscip Healthc. 2024 Dec 31;17:6255-6264. doi: 10.2147/JMDH.S496819. eCollection 2024.
3
Age- and oxidative stress-induced centrosome amplification and renal stones in Drosophila Malpighian tubules.
Biol Open. 2024 Dec 15;13(12). doi: 10.1242/bio.061743. Epub 2024 Dec 16.
4
Metabolic syndrome and the urinary microbiome of patients undergoing percutaneous nephrolithotomy.
Asian J Urol. 2024 Apr;11(2):316-323. doi: 10.1016/j.ajur.2022.08.007. Epub 2023 Mar 21.
5
Dysregulated palmitic acid metabolism promotes the formation of renal calcium-oxalate stones through ferroptosis induced by polyunsaturated fatty acids/phosphatidic acid.
Cell Mol Life Sci. 2024 Feb 12;81(1):85. doi: 10.1007/s00018-024-05145-y.
6
Patterns of weight change during adulthood and incidence of nephrolithiasis: a population-based study.
Int J Obes (Lond). 2024 Apr;48(4):461-468. doi: 10.1038/s41366-023-01434-x. Epub 2023 Dec 9.
7
Effect of Two Different Dietary Weight Loss Strategies on Risk Factors for Urinary Stone Formation and Cardiometabolic Risk Profile in Overweight Women.
Nutrients. 2022 Nov 27;14(23):5054. doi: 10.3390/nu14235054.
8
Association of Gut Microbiota and Biochemical Features in a Chinese Population With Renal Uric Acid Stone.
Front Pharmacol. 2022 May 19;13:888883. doi: 10.3389/fphar.2022.888883. eCollection 2022.
9
Nutritional status assessed by the Controlling Nutritional Status (CONUT) score as a predictor of recurrence of urolithiasis.
Investig Clin Urol. 2021 Sep;62(5):553-559. doi: 10.4111/icu.20210031. Epub 2021 Jul 19.
10
CT-related parameters and Framingham score as predictors of spontaneous passage of ureteral stones ≤ 10 mm: results from a prospective, observational, multicenter study.
Urolithiasis. 2021 Jun;49(3):227-237. doi: 10.1007/s00240-020-01214-6. Epub 2020 Sep 27.
本文引用的文献
1
Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits.
J Nephrol. 2018 Jun;31(3):395-403. doi: 10.1007/s40620-017-0453-3. Epub 2017 Oct 31.
2
Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.
PLoS One. 2017 Oct 26;12(10):e0184506. doi: 10.1371/journal.pone.0184506. eCollection 2017.
3
Vascular Disease and Kidney Stones: Abdominal Aortic Calcifications Are Associated with Low Urine pH and Hypocitraturia.
J Endourol. 2017 Sep;31(9):956-961. doi: 10.1089/end.2017.0350. Epub 2017 Jul 7.
4
Computerized Tomography Based Diagnosis of Visceral Obesity and Hepatic Steatosis is Associated with Low Urine pH.
J Urol. 2017 Nov;198(5):1085-1090. doi: 10.1016/j.juro.2017.05.079. Epub 2017 Jun 3.
5
Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):476-482. doi: 10.2215/CJN.06600616. Epub 2017 Feb 1.
6
Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography.
Eur J Radiol Open. 2016 Aug 2;3:195-9. doi: 10.1016/j.ejro.2016.07.004. eCollection 2016.
7
Obesity and urolithiasis: evidence of regional influences.
Urolithiasis. 2017 Jun;45(3):271-278. doi: 10.1007/s00240-016-0908-3. Epub 2016 Aug 3.
8
Type 2 diabetes mellitus and renal stones.
Adv Biomed Res. 2015 Aug 31;4:180. doi: 10.4103/2277-9175.164012. eCollection 2015.
9
Visceral obesity: A new risk factor for stone disease.
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E795-9. doi: 10.5489/cuaj.3145. Epub 2015 Nov 4.
10
Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature.
J Endourol. 2016 Mar;30(3):246-53. doi: 10.1089/end.2015.0567. Epub 2016 Jan 22.
Zotero 插件